FDA Approves Gardenia-Based Blue Dye for Use in Foods and Drinks
FDA Sends Warning Letters to Companies Selling Illegal Opioid Compound
7-hydroxymitragynine is not approved for use as dietary supplement, food additive, or drug ingredient
Certain Factors May Predict Weight Fluctuations After GLP-1 Receptor Agonist Treatment
Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction
Atopic Dermatitis May Be Linked to Increased Risk for CKD
Association between AD and increased risk for chronic kidney disease seen for men and women and in all age groups
High Dietary Inflammatory Index Tied to Increased Prevalence of Eczema
Significant sex interaction observed, with stronger associations in the female group
Prevalence, Incidence of Eczema Increase With Severity of Alopecia Areata
Those with moderate-to-severe versus mild AA had 78 percent higher risk for being diagnosed with atopic dermatitis
Management of Chronic Rhinosinusitis May Be Improving
Authors say reductions in symptom severity are due to clinical practice and not anatomical variation
CDC Says COVID-19 Cases Rising in 25 States
Bread Sold at Walmart, Kroger Recalled for Hazelnut Allergy
Adding Anxiety as Qualifier for Medical Cannabis Increases Number of Certifications
After addition of anxiety as qualifying condition, 60.26 percent of certifications were for anxiety
